| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |